Tuesday 12 November 2013

Mastitis and epidemiology


Some provocative arguments about epidemiology by Alex Broadbent, a philosopher of epidemiology in Johannesburg (SA), on his epidemiology blog.

“(1) It is hard to use results which one reasonably suspects might soon be found incorrect.”
“(2) Often, epidemiological results are such that a prospective user reasonably suspects that they will soon be found incorrect.”
“(3) Therefore, often, it is hard to use epidemiological results.”

 “I think that (1) does not need supporting: it is obviously true (or obviously enough for these purposes). The weight is on (2), and my argument for (2) is that from the outside, it is simply too hard to tell whether a given issue – for example, the effect of HRT on heart disease, or the effect of acetaminophen (paracetamol) on asthma – is still part of an ongoing debate, or can reasonably be regarded as settled. The problem infects even results that epidemiologists would widely regard as settled: the credibility of the evidence on the effect of smoking on lung cancer is not helped by reversals over HRT, for example, because from the outside, it is not unreasonable to wonder what the relevant difference is between the pronouncements on HRT and the pronouncements on lung cancer and smoking. There is a difference: my point is that epidemiology lacks a clear framework for saying what it is.”

 (Alex Broadbent on his Philosophy of Epidemiology Blog, 2 september 2012) 
ttp://philosepi.wordpress.com/author/philosepi/page/2/

Do these arguments affect the epidemiological results of mastitis investigations?


There were no comments on Broadbent’s blog, and I do not think mine will raise comments either, but feel free if you want.

No comments:

Post a Comment